Ads
related to: roche stock
Search results
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...
Benzinga· 3 days agoGoldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU
Zacks via Yahoo Finance· 5 days agoHalozyme (HALO) is set to benefit from the new patent grant in the EU, ensuring the protection of...
Nuclear position and local acetyl-CoA production regulate chromatin state - Nature
Nature· 6 days agoAnalyses of histone acetylation in Drosophila wing imaginal discs reveal distinct patterns of acetylation and cellular metabolism that affect gene expression and cell specification.
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Zacks via Yahoo Finance· 7 days agoInari's (NARI) VTE products are driving its top line on the back of robust adoption. The company is...
Barbara Corcoran’s Favorite Things — And Where to Get Them Cheaply
GoBankingRates via AOL· 4 days agoMarketers have been using celebrity recommendations to make advertisements believable and to...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 7 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 6 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We ...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks· 4 days agoFree Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important ...
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Zacks· 7 days agoThe adoption of these products is rising on the back of their features, including minimally invasive, novel, catheter-based mechanical thrombectomy devices and their accessories to address the ...
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Zacks· 5 days agoFree Report) . Will the recent positive trend continue leading up to its next earnings release, or is Halozyme Therapeutics due for a pullback? Before we dive into how investors and analysts ...